NCT01031199 - Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Positron-Emission TomographyMultiple Sclerosis

Interventions

DRUG

F-18 FEDAA1106 (BAY85-8101)

MS/CIS patients: Single intravenous bolus of 140 MBq BAY85-8101 ± 15% (ca. 5 mSv), applied mass of tracer \< 5 µg, PET

DRUG

F-18 FEDAA1106 (BAY85-8101)

Healthy controls: Single intravenous bolus of 140 MBq BAY85-8101 ± 15% (ca. 5 mSv), applied mass of tracer \< 5 µg, PET

Trial Locations (2)

Heidelberg

Stockholm